The company's principal activity is to develop, manufacture and market generic drugs for the ethical and over-the-counter markets. A generic drug is a pharmaceutical product, which is the chemical and therapeutic equivalent of a brand name drug as to which the patent and/or market exclusivity has expired. The company's present product portfolio includes 18 products in 35 strengths in 82 package sizes. The products relate to a variety of therapeutic segments including the central nervous system, cardiology, pain management and diabetes. The customers include wholesalers, buying groups, hospitals, nursing homes and retail pharmacies.
